Abstract:The class A G protein‐coupled receptor cholecystokinin 1 (CCK1) plays a predominant role in regulating exocrine pancreatic secretion both in mammals and in birds. CCK1R supra‐maximal stimulation leads to one of the most commonly used murine models of acute pancreatitis. The CCK‐CCK1R system is a well conserved feeding regulator in evolution from worms, insects, other invertebrates, vertebrates, to primates. In the murine brain, CCK1R is mainly expressed in the hippocampus and a few highly defined extracortical regions. These expression patterns determine that CCK1R modulation is important in both biology and medicine. Indeed some special characteristics revealed recently have made CCK1 stand out among all the class A GPCR. Although CCK1 is not susceptible to superoxide or hydrogen peroxide oxidative regulation, it is permanently activated by singlet oxygen (1O2) which can be generated conveniently in a Type II photodynamic action. We have used Fura‐2 fluorescent calcium imaging to show that CCK1R is activated permanently by photodynamic action with photosensitiser sulphonated aluminium phthalocyanine (SALPC) in the freshly isolated rat pancreatic acini. Such permanent photodynamic activation of CCK1R with SALPC could be reproduced in rat pancreatic acinar tumor cell AR4‐2J, and in cell lines ectopically expressing human hCCK1R. Both CCK1R in AR4‐2J and ectopically expressed in other cell lines (CHO, HEK) could be permanently activated by photodynamic action with the genetically encoded protein photosensitisers KillerRed and miniSOG. Other than permanent activation by 1O2, CCK1R activation by CCK in the freshly isolated rat pancreatic acini is quenched by mixed reactive oxygen species generated by neutrophil respiratory burst, and by neutrophil extracellular trap component histones. Further, CCK1R activation by CCK or by 1O2 in AR4‐2J is sensitized by histones. Our ongoing work is examining the potential for CCK1R analogues from invertebrates to be permanently activated by photodynamic action with SALPC, KillerRed, miniSOG or their variants. We are also looking at the possibility to extend the permanent activation by 1O2 (pAb1O2) property of CCK1R to other GPCR by the generation of chimeric receptors. The outcomes of such experiments will provide useful toolkits for remote photon‐driven activations of the CCK1R system in vivo from invertebrates to vertebrates, birds, mammals and non‐human primates.Support or Funding InformationThis work was supported by The Natural Science Foundation of China (31670856).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Development of a CCK1R-membrane Nanoparticle As a Fish-out Tool for Bioactive Peptides.

Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling

Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor

Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol

Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding

Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor

Mechanism of activation of a G protein-coupled receptor, the human cholecystokinin-2 receptor

A novel, quantitative bio-assay for cholecystokinin type-1 receptor activity in the anaesthetised rat

Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling

Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling

CCK1 ‐ a Very Peculiar G Protein‐Coupled Receptor

Structural insights into human brain–gut peptide cholecystokinin receptors

Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity

Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin

Cholesterol-dependent dynamic changes in the conformation of the type 1 cholecystokinin receptor affect ligand binding and G protein coupling

Preparation and Application of a Novel Molecularly Imprinted Solid-Phase Microextraction Monolith for Selective Enrichment of Cholecystokinin Neuropeptides in Human Cerebrospinal Fluid.

Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy

Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor

Structural basis for ligand recognition and G protein-coupling promiscuity of the cholecystokinin A receptor

Convenient and Efficient Synthesis of a Lanthanide-Coordinated, Diethylene Triamine Pentaacetic Acid Labeled Biopolymer As an Assay for the Cholecystokinin B Receptor.

Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe